Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. It offers dermatology products, hospital acute care products, out-licensed products, and specialty medicine. The company was founded on January 9, 2004 and is headquartered in Mississauga, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cipher Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cipher Pharmaceuticals Inc market cap is $451.52M.
What is the 52-week high for Cipher Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cipher Pharmaceuticals Inc 52 week high is $19.63 as of May 04, 2026.
What is the 52-week low for Cipher Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cipher Pharmaceuticals Inc 52 week low is $11.87 as of May 04, 2026.
What is Cipher Pharmaceuticals Inc stock price today?
Cipher Pharmaceuticals Inc stock price today is $18.09.
What was Cipher Pharmaceuticals Inc stock price yesterday?
Cipher Pharmaceuticals Inc stock price yesterday was $17.86.
What is the PE ratio of Cipher Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cipher Pharmaceuticals Inc's P/E ratio is 11.94.
What is the Price-to-Book ratio of Cipher Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cipher Pharmaceuticals Inc P/B ratio is 2.6092.
What is the 50-day moving average of Cipher Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cipher Pharmaceuticals Inc 50-day moving average is $17.06.